NanoMed Pharmaceuticals is a specialty pharmaceutical company dedicated to developing improved therapeutic products to treat cancer and other serious diseases. The company’s core technology is Nanotemplate Engineering™, a proprietary nanoparticle manufacturing technology used to formulate small molecules, peptides, proteins, plasmid DNA, and diagnostic agents. NanoMed is headquartered in Kalamazoo, Michigan.
The compound in NanoMed’s lead product, NMP-139, is a FDA-approved cytotoxic drug used to treat several types of cancer.
Discover more about Nanotechnology and Nanotemplate Engineering